Kato
Kato Brand names, Kato Analogs
- Abitrate
- Aplactan
- Aplexal
- Apotomin
- Artate
- Carecin
- Cerebolan
- Cerepar
- Chlorophenoxyisobutyricacidethylester
- Cinaperazine
- Cinazyn
- Cinnacet
- Cinnageron
- Cinnarizine Stugeron
- Clofibrate
- Corathiem
- Denapol
- Dimitron
- Dimitronal
- Eglen
- Folcodal
- Giganten
- Glanil
- Hilactan
- Ixertol
- Katoseran
- Labyrin
- Lazeta
- Marisan
- Midronal
- Mitronal
- Olamin
- Processine
- Sedatromin
- Sepan
- Siptazin
- Spaderizine
- Stugeron
- Stutgeron
- Stutgin
- Toliman
Kato Brand Names Mixture
- No information avaliable
Kato Chemical_Formula
C26H28N2
Kato RX_link
No information avaliable
Kato fda sheet
Kato msds (material safety sheet)
Kato Synthesis Reference
No information avaliable
Kato Molecular Weight
368.514 g/mol
Kato Melting Point
No information avaliable
Kato H2O Solubility
750 mg/L
Kato State
Solid
Kato LogP
5.63
Kato Dosage Forms
No information avaliable
Kato Indication
For the treatment of vertigo/meniere's disease, nausea and vomiting, motion sickness and also useful for vestibular symptoms of other origins.
Kato Pharmacology
Cinnarizine is an antihistamine and a calcium channel blocker. Histamines mediate a number of activities such as contraction of smooth muscle of the airways and gastrointestinal tract, vasodilatation, cardiac stimulation, secretion of gastric acid, promotion of interleukin release and chemotaxis of eosinophils and mast cells. Competitive antagonists at histamine H1 receptors may be divided into first (sedating) and second (non-sedating) generation agents. Some, such as Cinnarizine also block muscarinic acetylcholine receptors and are used as anti-emetic agents. Cinnarizine through its calcium channel blocking ability also inhibits stimulation of the vestibular system.
Kato Absorption
No information avaliable
Kato side effects and Toxicity
No information avaliable
Kato Patient Information
No information avaliable
Kato Organisms Affected
Humans and other mammals
